title: [Medical treatment for Cushing's syndrome].
abstract: Systemic cortisol plays an important role in the metabolism of glucose, lipids and proteins, as well as in the regulation of electrolyte balance. It is well known that the development of the microvascular disease of various organs such as the heart and kidney, in patients with diabetes mellitus, hyperlipidemia and hypertension of which disorders are frequently associated with Cushing's syndrome. Thus, we should treat Cushing's syndrome as soon as possible, since many complications, including cardiovascular diseases and infections, will soon occur when the definite diagnosis is delayed. Adrenalectomy is essential for treatment for Cushing's syndrome even in the patients with pituitary or ectopic ACTH-producing tumor. Some case can not be treated with surgical procedures because of worsened conditions with several complications of infection and diabetes. Then we choose medical treatment. Medical adrenalectomy is achieved by using with mitotane which is usually used for adrenocortical cancer. We commonly treat the patients with Cushing's syndrome due to adrenal tumor and pituitary or ectopic ACTH producing tumor by using metyrapone which mainly inhibits 11-hydroxylase. Metyrapone is also recommended to treat the patients who are not well differentiated Cushing's disease from ectopic ACTH syndrome. We rarely use trilostane which is an inhibitor against 3beta-hydroxysteroid dehydrogenase (3beta-HSD). Replacement therapy with hydrocortisone should be considered if adrenal failure will occur during treatment with those drugs.
authors.affiliation: Department of Medicine, Yokohama Rosai Hospital.
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Nishikawa
authors.forename: Jun
authors.initials: J
authors.lastname: Saito
authors.forename: Masao
authors.initials: M
authors.lastname: Omura
mesh_terms: D000616:Aminoglutethimide / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000188:drug therapy*; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008797:Metyrapone / Q000627:therapeutic use; D013252:Steroid 11-beta-Hydroxylase / Q000037:antagonists & inhibitors
chemical_list: D047072:Aromatase Inhibitors; D000616:Aminoglutethimide; D013252:Steroid 11-beta-Hydroxylase; D007654:Ketoconazole; D008797:Metyrapone